Drug Development Consulting Holding ApS
CVR 42285722 · Private limited company (ApS) · Active · Medium risk
Drug Development Consulting Holding ApS is a Private limited company (ApS), founded on , based in Brøndby. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 32.6m and a net result of DKK -61.4m. CEO: René Holmen Pedersen.
Bankruptcy risk for Drug Development Consulting Holding ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42285722
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (5 years)
- Address
- c/o KLIFO A/S, Abildager 24
2605 Brøndby - Municipality
- Brøndby
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 364k
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 5 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 68.7% |
| Current ratio | 527% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 5 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -92k | DKK -116k | DKK -53k |
| Net profit | DKK -61.4m | DKK -13.3m | DKK -9.4m |
| Equity | DKK 32.6m | DKK 79.1m | DKK 70.5m |
| Total assets | DKK 47.4m | DKK 79.2m | DKK 70.5m |
| Cash | DKK 116k | DKK 153k | – |
| Short-term debt | DKK 22k | DKK 22k | – |
| Tax owed | DKK 0 | DKK 0 | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Independent Auditor’s Report · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 136 | ||
| 1 Jan 2023 – 31 Dec 2023 | 123 | ||
| 1 Jan 2022 – 31 Dec 2022 | 167 | ||
| 7 Apr 2021 – 31 Dec 2021 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | René Holmen Pedersen | Current | |
| CEO | Jasper Michiel van Gorp | ||
| CEO | Alejandra Maria Cristina Bonifacini Mørk | ||
| CEO | Rasmus Koch Nelund | ||
| Board | Redmar Koene | Current | |
| Board | Alejandra Maria Cristina Bonifacini Mørk | Current | |
| Board | Niels Peder Nielsen | Current | |
| Board | Rafael Natanek | Current | |
| Board | Mette Kirstine Agger | ||
| Board | Rafael Natanek | ||
| Owner (15%) | DDC Mørk Holding ApS | Current | |
| Owner (67%) | GHS III Midco B.V. | Current | |
| Owner (100%) | Coöperatieve Gilde Healthcare Services III U.A. | ||
| Owner (25%) | Mørk Consulting ApS | ||
| Owner (67%) | Coöperatieve Gilde Healthcare Services III U.A. | ||
| Owner (25%) | DDC Mørk Holding ApS | ||
| Owner (67%) | Coöperatieve Gilde Healthcare Services III U.A. | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Founder | Coöperatieve Gilde Healthcare Services III U.A. | Current |
The CEOs' other companies
René Holmen Pedersen – 3 other companies
- Drug Development Consulting BidCo ApS Active
- KLIFO A/S Active
- TFS TRIAL FORM SUPPORT ApS Active
Alejandra Maria Cristina Bonifacini Mørk – 11 other companies
- DDC Mørk Holding ApS Active
- Drug Development Consulting BidCo ApS Active
- Epoqe Pharma ApS Active
- HERON HOLDING A/S Opløst
- KLIFO A/S Active
- Life Science Legal ApS Active
- Loma Therapeutics ApS Active
- Mørk Consulting ApS Active
- Phillips-Medisize A/S Active
- Scandion Oncology A/S Opløst
- TAKEDA PHARMA A/S Active
Rasmus Koch Nelund – 10 other companies, of which 2 bankrupt
- PIPELINE BIOTECH A/S Bankrupt 31 May 2016
- RR Blockchain Operations ApS Bankrupt 30 Nov 2022
- ADDICO ApS Compulsorily dissolved
- ANSN ApS Active
- CAVEO ApS Compulsorily dissolved
- Drug Development Consulting BidCo ApS Active
- HERAX METHODS A/S Opløst
- KLIFO A/S Active
- Life Sciences Advisory ApS Active
- PASSION & DISCIPLINE ApS Active
Address history (2 moves)
| c/o KLIFO A/S, Abildager 24, 2605 Brøndby | |
| Smedeland 36, 2600 Glostrup | |
| Axeltorv 2, 1609 København V |
Similar companies in Brøndby
- A/S HOFFMANN'S ERHVERVSBEKLÆDNING Brøndby
- Already and not yet ApS Brøndby
- Say Capital Holding ApS Brøndby Strand
- IKON-TJF Holding ApS Brøndby
- MYA Holding ApS Brøndby
- EA Entreprise ApS Brøndby
- Begum Holding ApS Brøndby Strand
- MZTDHM ApS Brøndby Strand
- Balouis Holding ApS Brøndby
- Nemeth Invest ApS Brøndby
- ADK 2026 HOLDING ApS Brøndby Strand
- JPHolland Holding ApS Brøndby
Questions and answers about Drug Development Consulting Holding ApS
Has Drug Development Consulting Holding ApS gone bankrupt?
No, Drug Development Consulting Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Drug Development Consulting Holding ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Drug Development Consulting Holding ApS?
René Holmen Pedersen is the CEO of Drug Development Consulting Holding ApS.
Who is the auditor of Drug Development Consulting Holding ApS?
Drug Development Consulting Holding ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Drug Development Consulting Holding ApS founded?
Drug Development Consulting Holding ApS was founded on 7 April 2021.
What is the equity of Drug Development Consulting Holding ApS?
Equity was DKK 32.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.